Surgical Specialties Corp:企業の戦略・SWOT・財務分析

◆英語タイトル:Surgical Specialties Corp - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4950
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Surgical Specialties Corp – Strategy, SWOT and Corporate Finance Report
Summary

Surgical Specialties Corp – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Surgical Specialties Corp (Surgical Specialties), formerly Angiotech Pharmaceuticals, is a medical devices company engaged in the development, manufacturing and marketing of surgical instruments. The company designs and manufactures high performance surgical knives and wound closure products. Its portfolio encompasses a comprehensive range of sutures including bidirectional and unidirectional barbed sutures, traditional sutures,specialty-sized sutures; knives and related surgical supplies comprising incision knives, crescent knives, guarded knives, groove and limbal relaxation incision knives; and vitrectomy Knives, among others. The company operates in the US, Canada, and Europe. Surgical Specialties is headquartered in Wyomissing, Pennsylvania, the US.

Scope

- Detailed information on Surgical Specialties Corp required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Surgical Specialties Corp in the form of a SWOT analysis
- An in-depth view of the business model of Surgical Specialties Corp including a breakdown and examination of key business segments
- Intelligence on Surgical Specialties Corp’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Surgical Specialties Corp, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Surgical Specialties Corp and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Surgical Specialties Corp as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Surgical Specialties Corp’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Surgical Specialties Corp: Company Overview
Surgical Specialties Corp: Overview and Key Facts
Surgical Specialties Corp: Overview
Surgical Specialties Corp: Key Facts
Surgical Specialties Corp: Key Employees
Surgical Specialties Corp: Key Employee Biographies
Surgical Specialties Corp: Major Products and Services
Surgical Specialties Corp: Company History
Surgical Specialties Corp: Locations and Subsidiaries
Surgical Specialties Corp: Key Competitors
Surgical Specialties Corp: Company Analysis
Surgical Specialties Corp: Business Description
Surgical Specialties Corp: SWOT Analysis
Surgical Specialties Corp: SWOT Overview
Surgical Specialties Corp: Strengths
Surgical Specialties Corp: Weaknesses
Surgical Specialties Corp: Opportunities
Surgical Specialties Corp: Threats
Surgical Specialties Corp: Corporate Financial Deals Activity
Surgical Specialties Corp: Financial Deals Overview
Surgical Specialties Corp: Top Deals 2016 – 2020YTD*
Surgical Specialties Corp: Advisors
Surgical Specialties Corp: Top Legal Advisors
Surgical Specialties Corp: Divestments
Surgical Specialties Corp: Private Equity and Ownership
Surgical Specialties Corp: Recent Developments
Surgical Specialties Corp: News and Events Summary
Surgical Specialties Corp: Financial Deals
Surgical Specialties Corp: Regulatory and Legal Events
Surgical Specialties Corp: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Surgical Specialties Corp: Key Facts
Table 2: Surgical Specialties Corp: Key Employees
Table 3: Surgical Specialties Corp: Company History
Table 4: Surgical Specialties Corp: Locations and Subsidiaries
Table 5: Surgical Specialties Corp: Key Competitors
Table 6: Surgical Specialties Corp: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Surgical Specialties Corp: Top Deals 2016 - 2020YTD*
Table 8: Surgical Specialties Corp: Legal Advisor Ranking by Value (US$m)
Table 9: Surgical Specialties Corp: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 10: Surgical Specialties Corp: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 11: Surgical Specialties Corp: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 12: Surgical Specialties Corp: News and Events Summary
Table 13: Surgical Specialties Corp: Financial Deals
Table 14: Surgical Specialties Corp: Regulatory and Legal Events
Table 15: Surgical Specialties Corp: Strategy and Operations

★海外企業調査レポート[Surgical Specialties Corp:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adynxx Inc (ADYX):企業の財務・戦略的SWOT分析
    Summary Adynxx Inc (Adynxx), formerly known as Alliqua BioMedical, Inc, is a clinical stage biopharmaceutical company. It utilizes AYX transcription factor decoys to create therapies with disease changing properties. The company is involved in the development of transcription factor decoy technology …
  • Activision Blizzard, Inc.:企業の戦略・SWOT・財務情報
    Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report Summary Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • X-Chem Inc-製薬・医療分野:企業M&A・提携分析
    Summary X-Chem Inc (X-Chem) is a biotechnology company that focuses on applying its innovative drug discovery platform to the generation of novel small molecule therapeutics. The company’s drug discovery engine is based on a library generated by iterative combinatorial synthesis of small molecules. …
  • Toro Energy Limited (TOE):企業の戦略的SWOT分析
    Toro Energy Limited (TOE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • AA PLC:企業の戦略・SWOT・財務分析
    AA PLC - Strategy, SWOT and Corporate Finance Report Summary AA PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Prezzo Ltd:企業の戦略・SWOT・財務情報
    Prezzo Ltd - Strategy, SWOT and Corporate Finance Report Summary Prezzo Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Owen Mumford Ltd:企業の戦略的SWOT分析
    Owen Mumford Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Pernod Ricard SA (RI):企業の財務・戦略的SWOT分析
    Pernod Ricard SA (RI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Zhejiang Yatai Pharmaceutical Co Ltd (002370):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Yatai Pharmaceutical Co Ltd (Yatai Pharmaceutical), formerly Asia-Pacific Pharmaceutical Factory, is a pharmaceutical company. The company develops, researches, and manufactures pharmaceuticals including penicillin, cephalosporins and hormones. It offers transdermal controlled-relea …
  • China Suntien Green Energy Co Ltd (956):企業の財務・戦略的SWOT分析
    China Suntien Green Energy Co Ltd (956) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Warpaint London plc (W7L):企業の財務・戦略的SWOT分析
    Warpaint London plc (W7L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • LifePoint Health Inc (LPNT):製薬・医療:M&Aディール及び事業提携情報
    Summary LifePoint Health Inc (LifePoint) is a healthcare service provider which operates community hospitals, physician practices, outpatient centers, post-acute facilities and regional health systems. The company along with its subsidiaries delivers a range of medical and surgical services to non-u …
  • Softchoice Corporation:企業の戦略的SWOT分析
    Softchoice Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Meiji Co Ltd:企業の戦略・SWOT・財務分析
    Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Jungheinrich AG:戦略・SWOT・企業財務分析
    Jungheinrich AG - Strategy, SWOT and Corporate Finance Report Summary Jungheinrich AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Iproteos SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Iproteos SL (Iproteos) is a biotechnology company that develops therapeutic drugs for human diseases. The company develops drugs to treat various therapeutic indications such as cognitive impairment associated with schizophrenia, epilepsy, paediatric cancer, and others. It provides research …
  • Mylan NV (MYL):医療機器:M&Aディール及び事業提携情報
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines, and consumer healthcare products. It offers pharmaceutical products in multiple forms for various disease conditions related to respiratory and allerg …
  • Edgars Stores Limited:企業の戦略・SWOT・財務情報
    Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report Summary Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vior Inc (VIO):企業の財務・戦略的SWOT分析
    Summary Vior Inc (Vior) is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of gold and silver metal properties in North and Latin America. Its projects comprise Mosseau Gold project, Foothills Rutile project, Vezza-Noyard Go …
  • The Schwan Food Company:戦略・SWOT・企業財務分析
    The Schwan Food Company - Strategy, SWOT and Corporate Finance Report Summary The Schwan Food Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆